Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
3.02
Dollar change
-1.44
Percentage change
-32.29
%
Index- P/E- EPS (ttm)- Insider Own21.42% Shs Outstand21.18M Perf Week60.64%
Market Cap63.96M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float16.64M Perf Month19.84%
Income- PEG- EPS next Q-0.15 Inst Own0.76% Short Float0.22% Perf Quarter-14.69%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.88 Perf Half Y-
Book/sh-0.03 P/B- EPS next Y- ROA- Short Interest0.04M Perf Year-
Cash/sh0.09 P/C34.39 EPS next 5Y- ROE- 52W Range1.58 - 4.90 Perf YTD20.32%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-38.37% Beta-
Dividend TTM- Quick Ratio0.76 Sales past 5Y- Gross Margin- 52W Low91.14% ATR (14)0.53
Dividend Ex-Date- Current Ratio0.76 EPS Y/Y TTM- Oper. Margin- RSI (14)55.54 Volatility40.10% 20.85%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price12.67
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-76.49% Payout- Rel Volume8.51 Prev Close4.46
Sales Surprise-100.00% EPS Surprise-50.00% Sales Q/Q- EarningsNov 15 BMO Avg Volume40.72K Price3.02
SMA2032.60% SMA5014.67% SMA200-1.34% Trades Volume346,646 Change-32.29%
Nov-15-24 09:47AM
Nov-04-24 07:00AM
Oct-30-24 08:51AM
Oct-28-24 04:44PM
Oct-24-24 08:46AM
09:22AM Loading…
Oct-17-24 09:22AM
Oct-03-24 08:00AM
Sep-13-24 08:09AM
Sep-12-24 07:59AM
Sep-11-24 08:15AM
Sep-05-24 08:22AM
Aug-29-24 07:53AM
Aug-22-24 08:00AM
06:00AM
Aug-21-24 05:00AM
08:30AM Loading…
Aug-19-24 08:30AM
Aug-15-24 08:30AM
Aug-09-24 09:00AM
Aug-06-24 08:35AM
Aug-02-24 08:55AM
Jul-31-24 06:21PM
Jul-24-24 10:48AM
Jun-03-24 12:44PM
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.